MIR222HG is associated with PC progression to CRPC, increases androgen-independent cell growth and represses the expression of TMPRSS2 and FKBP5 in hormone-sensitive prostate cancer [44]. This evidence concerns the gene FKBP5 and pachyonychia congenita.